Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Rheumatology | Monthly Briefing

Back to Journal Articles

November 2009 Briefing - Rheumatology

Last Updated: December 01, 2009.

 

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for November 2009. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Elders With Chronic Pain More Likely to Suffer Falls

TUESDAY, Nov. 24 (HealthDay News) -- Elderly people who have to contend with chronic pain are more likely to sustain a fall than their counterparts with little or no pain, according to a study published in the Nov. 25 issue of the Journal of the American Medical Association, while a study published in the Nov. 23 issue of the Archives of Internal Medicine found that the use of psychotropic medications also increases the risk of falls in elderly patients.

Abstract - Leveille
Full Text (subscription or payment may be required)
Abstract - Woolcott
Full Text (subscription or payment may be required)

Most Medical Journals Have Conflict of Interest Policies

TUESDAY, Nov. 24 (HealthDay News) -- Most high impact factor journals have publicly available conflict of interest statement policies, but there is a great deal of variation among journals, which could be confusing for authors, according to a study in the Nov. 25 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

Rofecoxib Cardiovascular Risk Apparent in Late 2000

MONDAY, Nov. 23 (HealthDay News) -- Dozens of studies on rofecoxib revealed its association with an increased risk of cardiovascular events nearly three and a half years before it was voluntarily withdrawn by maker Merck and Company, according to a study in the Nov. 23 issue of the Archives of Internal Medicine.

Abstract
Full Text

Study Provides Insight Into Bone-Overgrowth Disease

THURSDAY, Nov. 19 (HealthDay News) -- In patients with fibrodysplasia ossificans progressiva (FOP), a mutation in the ACVR1 receptor appears to promote cartilage formation by inducing bone morphogenetic protein (BMP) signaling, according to research published in the November issue of the Journal of Clinical Investigation.

Full Text

Childhood Esophageal Atresia Linked to Adult Scoliosis

THURSDAY, Nov. 12 (HealthDay News) -- Adults with a history of esophageal atresia repair during infancy face a substantially higher risk of scoliosis, according to research published online Nov. 9 in Pediatrics.

Abstract
Full Text (subscription or payment may be required)

Study Finds Costs of Quality Programs Burden Practices

WEDNESDAY, Nov. 11 (HealthDay News) -- The cost of providing data and support for health system quality-improvement programs can put a significant burden on primary care practices, and changes in the outcomes of trials are often made without being disclosed, according to two studies in the November/December Annals of Family Medicine.

Abstract - Halladay
Full Text
Abstract - Ewart
Full Text

Muscle Strength May Lower Alzheimer's Disease Risk

WEDNESDAY, Nov. 11 (HealthDay News) -- Older individuals with greater muscular strength may have a lower risk of developing mild cognitive impairment and Alzheimer's disease, according to research published in the November issue of the Archives of Neurology.

Abstract
Full Text (subscription or payment may be required)

Medical Errors Disclosure Can Help Physicians and Patients

WEDNESDAY, Nov. 11 (HealthDay News) -- Physicians are willing to share their experiences of making diagnostic errors, and analyzing them systematically helps point the way to improve future diagnoses, according to a study in the Nov. 9 issue of the Archives of Internal Medicine, while a second study in the same issue found that patients give higher quality ratings when adverse events are disclosed.

Abstract - Schiff
Full Text (subscription or payment may be required)
Abstract - Lopez
Full Text (subscription or payment may be required)

Arthritis Drugs Unlikely to Increase Cancer Risk

MONDAY, Nov. 9 (HealthDay News) -- Rheumatoid arthritis (RA) patients who start taking anti-tumor necrosis factor α (anti-TNFα) drugs are not likely to have a higher risk of developing cancer than other groups of RA patients, according to a Swedish study in the November issue of Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Rheumatoid Arthritis Therapy Options, Costs Analyzed

FRIDAY, Nov. 6 (HealthDay News) -- Treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs (DMARDs) is more cost-effective than the pyramid therapy, but, for now, biologics should be reserved for disease of longer duration or that is unresponsive to other treatment, according to a study in the Nov. 3 Annals of Internal Medicine.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Teriparatide May Help Treat Steroid-Induced Osteoporosis

THURSDAY, Nov. 5 (HealthDay News) -- In patients with glucocorticoid-induced osteoporosis, treatment with teriparatide is more effective than alendronate in increasing bone mineral density and preventing fractures, according to a study in the November issue of Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Stats Helps Paint Picture of H1N1 Hospitalizations

TUESDAY, Nov. 3 (HealthDay News) -- The age of people hospitalized with H1N1 influenza infection in California during the summer of 2009 was typically younger than the age commonly seen with seasonal influenza, and infants had the highest rates of hospitalization and those aged 50 and older had the highest mortality, according to research published in the Nov. 4 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Background Disease Rates Important in H1N1 Pandemic

MONDAY, Nov. 2 (HealthDay News) -- During mass immunization with pandemic H1N1 influenza vaccines, awareness of background rates of disease is essential for assessing vaccine safety, and may help allay vaccine-associated fears among the general public, according to an article published online Oct. 31 in The Lancet.

Abstract
Full Text (subscription or payment may be required)
Comment (subscription or payment may be required)

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Previous: November 2009 Briefing - Pulmonology Next: November 2009 Briefing - Surgery

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.